Value Bridge — UNIVERSITY OF WASHINGTON MED CTR
Current $-290M → Target $-246M (+$44.6M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-290.5M
Current EBITDA
$-245.9M
Target EBITDA
+$44.6M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$10.1M
Payer Mix Optimization
$24.2M
Cost to Collect Reduction
$8.1M
Clean Claim Improvement
$6.1M
Volume & Rate Growth
$40.3M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-290M to $-246M. The highest-impact lever is Volume & Rate Growth at $16.1M probability-weighted.
IC talking point: "We see $45M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $490M in equity value creation."